Immurcell Corp Files 2025 Proxy Statement
Ticker: ICCC · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Immurcell proxy filed - vote on exec pay & board nominees by June 12th.
AI Summary
Immurcell Corporation filed its definitive proxy statement on April 24, 2025, for its annual meeting on June 12, 2025. The company, based in Portland, Maine, is seeking shareholder approval for matters related to its corporate governance and operations. The filing details executive compensation, director nominations, and other proposals requiring shareholder votes.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial distress indicators.
Key Numbers
- 20250424 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
- 20250612 — Meeting Date (Date of the shareholder meeting for which this proxy statement is issued.)
Key Players & Entities
- IMMUCELL CORP (company) — Registrant
- 20250424 (date) — Filing Date
- 20250612 (date) — Meeting Date
- Portland, Maine (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is the Immurcell Corporation shareholder meeting scheduled?
The shareholder meeting is scheduled for June 12, 2025.
Where is Immurcell Corporation headquartered?
Immurcell Corporation is headquartered in Portland, Maine.
What type of company is Immurcell Corporation?
Immurcell Corporation is involved in the field of In Vitro & In Vivo Diagnostic Substances, classified under SIC code 2835.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 24, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding IMMUCELL CORP /DE/ (ICCC).